Federal Register / Vol. 75, No. 209 / Friday, October 29, 2010 / Notices 66771 

Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Blvd., Ste 703, Rm 7072, 

Bethesda, MD 20892–8329, 301–594–1408, 

Stoicaa2@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: October 25, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–27410 Filed 10–28–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Childhood 

Lead Poisoning Prevention (ACCLPP) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the CDC, National 

Center for Environmental Health 

(NCEH) announces the following 

committee meeting: 

Dates and Times: 

November 16, 2010, 8:30 a.m.–5 p.m. 

November 17, 2010, 8:30 a.m.–5 p.m. 

November 18, 2010, 8:30 a.m.–12 p.m. 

Place: The Westin Atlanta North at 

Perimeter, Seven Concourse Parkway, 

Atlanta, Georgia 30328, (770) 395–3900. 

Status: This meeting is open to the public, 

limited only by the space available. The 

meeting room accommodates approximately 

100 people. 

Purpose: The Committee provides advice 

and guidance to the Secretary; the Assistant 

Secretary for Health; and the Director, CDC, 

regarding new scientific knowledge and 

technological developments and their 

practical implications for childhood lead 

poisoning prevention efforts. The committee 

also reviews and reports regularly on 

childhood lead poisoning prevention 

practices and recommends improvements in 

national childhood lead poisoning 

prevention efforts. 

Matters to be Discussed: The agenda will 

include discussions on: (1) The New York 

State Childhood Lead Poisoning Program; (2) 

the Educational Intervention Workgroup; (3) 

the Laboratory Workgroup; (4) the Consumer 

Product Workgroup; (5) the National Health 

and Nutrition Examination Survey 

(NHANES) Blood Lead Estimate; (6) the 

Blood Lead Level of ‘‘Concern’’; (7) Federal 

agency updates; (8) discussion of CDC 

recommendations for lead in water; and (9) 

The Lead in Water Panel: The State of the 

Science panel discussions. 

Opportunities will be provided during the 

meeting for oral comments. 

Agenda items are subject to change as 

priorities dictate. 

For Further Information Contact: Claudine 

Johnson, Program Operation Assistant, Lead 

Poisoning Prevention Branch, Division of 

Environmental Emergency Health Services, 

NCEH, CDC, 4770 Buford Highway, NE., 

Mailstop F–60, Atlanta, GA 30341, telephone 

770 488–3629, fax 770 488–3635. 

The Director, Management Analysis and 

Services Office has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: October 22, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–27365 Filed 10–28–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, Glial Lineage in 

Disease Progression. 

Date: November 22, 2010. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Rockville, MD 20852. 

Contact Person: Norman Chang, PhD, 

Scientific Review Officer, Division of 

Scientific Review, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, NIH, 6100 Executive 

Blvd., Room 5B01, Bethesda, MD 20892, 

301–496–1485, changn@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: October 22, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–27331 Filed 10–28–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Cancer 

Institute Special Emphasis Panel, 

December 6, 2010, 8 a.m. to December 

6, 2010, 5 p.m., Bethesda North Marriott 

Hotel & Conference Center, 5701 

Marinelli Road, Bethesda, MD 20852 

which was published in the Federal 

Register on October 15, 2010, 

75FR63494. 

This notice is amending the start and 

end times of the meeting from 8 a.m.– 

5 p.m. to 8:30 a.m.–6 p.m. The meeting 

is closed to the public. 

Dated: October 22, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–27328 Filed 10–28–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES

66772 Federal Register / Vol. 75, No. 209 / Friday, October 29, 2010 / Notices 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Centers for Advanced Diagnostics and 

Experimental Therapeutics in Lung Diseases 

(CADET I). 

Date: November 18–19, 2010. 

Time: 6 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Keary A Cope, PhD, 

Scientific Review Officer, Office of Scientific 

Review, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7190, 

Bethesda, MD 20892–7924, (301) 435–2222, 

copeka@mail.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Common Pathogenetic Mechanisms of Lung 

Cancer and COPD. 

Date: November 19, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Robert T. Su, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7202, 

Bethesda, MD 20892–7924, 301–435–0297, 

sur@mail.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Next Generation Genetic Association Studies. 

Date: November 19, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications, 

Place: Westin BWI (Baltimore), 1100 Old 

Elkridge Landing Road, Baltimore, MD 

21090. 

Contact Person: David A Wilson, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7204, 

Bethesda, MD 20892–7924, 301–435–0299, 

wilsonda2@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: October 22, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–27319 Filed 10–28–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, Office 

of Infectious Diseases (BSC, OID) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 10:30 a.m.–12 p.m., 

November 15, 2010. 

Place: Teleconference. 

Status: Open to the public, the toll 

free dial in number is 1(800)369–1755 

with a pass code of 8481618. 

Purpose: The BSC, OID, shall advise 

the Secretary, Department of Health and 

Human Services; the Director, CDC; the 

Director, OID; and the Directors of the 

National Center for Immunization and 

Respiratory Diseases, the National 

Center for Emerging and Zoonotic 

Infectious Diseases, and the National 

Center for HIV/AIDS, Viral Hepatitis, 

STD, and TB Prevention, CDC, 

concerning strategies, goals, and 

priorities for the programs and research 

within the national centers and monitor 

the overall strategic direction and focus 

of OID and the national centers. 

Matters To Be Discussed: The meeting 

will involve the presentation of a draft 

document being developed to advance 

CDC’s infectious disease priorities. A 

subsequent meeting to solicit further 

discussion and input on the document 

from the board is currently scheduled 

for December 6, 2010 and will be 

announced at a future date. 

Requests for a copy of the draft 

document may be sent to 

ddidinput@cdc.gov prior to the 

teleconference. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Robin Moseley, CDC, OID, 1600 Clifton 

Road, NE., Mailstop D–10, Atlanta, 

Georgia 30333, telephone (404) 639– 

4461. 

The Director, Management and 

Analysis Services Office, has been 

delegated the authority to sign the 

Federal Register notices pertaining to 

announcements of meetings and other 

committee management activities for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: October 22, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–27462 Filed 10–28–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Meetings 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of meetings of the Sleep 

Disorders Research Advisory Board. 

The meetings will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Sleep Disorders 

Research Advisory Board. 

Date: November 12, 2010. 

Time: 3 p.m. to 5 p.m. 

Agenda: To discuss sleep research 

programs and sleep research strategic 

planning. Public meeting observers should 

call 1–800–779–2608 to access the 

teleconference and the observer passcode is 

7989226. Public meeting observers should 

send comments or questions for this meeting 

to the National Center on Sleep Disorders 

Research by e-mail mt2d@nih.gov or fax 301– 

480–3557. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Suite 10170, Bethesda, MD 

20892 (Telephone Conference Call.) 

Contact Person: Michael J Twery, PhD, 

Director, National Center on Sleep Disorders 

Research, Division of Lung Diseases, National 

Heart, Lung, and Blood Institute, National 

Institutes of Health, 6701 Rockledge Drive, 

Suite 10038, Bethesda, MD 20892–7952, 301– 

435–0199, twerym@nhlbi.nih.gov. 

Name of Committee: Sleep Disorders 

Research Advisory Board. 

Date: December 10, 2010. 

Time: 8:30 a.m. to 4 p.m. 

Agenda: To discuss sleep research 

programs and sleep research strategic 

planning. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C–Wing, 

Conference Room 6, Bethesda, MD 20892. 

Contact Person: Michael J Twery, PhD, 

Director, National Center on Sleep Disorders 

Research, Division of Lung Diseases, National 

Heart, Lung, and Blood Institute, National 

Institutes of Health, 6701 Rockledge Drive, 

Suite 10038, Bethesda, MD 20892–7952,301– 

435–0199, twerym@nhlbi.nih.gov. 

Any interested person may file written 

comments with the committee by 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES